Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide, Dexamethasone and PLD for Relapsed/Refractory Multiple Myeloma
NCT01541332Phase 2Unknown
- Sponsor
- ONCOtherapeutics
- Start
- Feb 2012
- Primary completion
- Dec 2016
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by ONCOtherapeutics. Status: unknown.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01541332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541332.